CH612678A5 - - Google Patents

Info

Publication number
CH612678A5
CH612678A5 CH1001576A CH1001576A CH612678A5 CH 612678 A5 CH612678 A5 CH 612678A5 CH 1001576 A CH1001576 A CH 1001576A CH 1001576 A CH1001576 A CH 1001576A CH 612678 A5 CH612678 A5 CH 612678A5
Authority
CH
Switzerland
Application number
CH1001576A
Inventor
Jean-Marie Teulon
Bernard Schweisguth
Jean-Claude Cognacq
Original Assignee
Hexachimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB33501/75A external-priority patent/GB1511694A/en
Application filed by Hexachimie filed Critical Hexachimie
Publication of CH612678A5 publication Critical patent/CH612678A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
CH1001576A 1975-08-12 1976-08-05 CH612678A5 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB33501/75A GB1511694A (en) 1975-08-12 1975-08-12 Pyridine derivatives
GB4518875 1975-10-31

Publications (1)

Publication Number Publication Date
CH612678A5 true CH612678A5 (xx) 1979-08-15

Family

ID=26261898

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1001576A CH612678A5 (xx) 1975-08-12 1976-08-05

Country Status (19)

Country Link
US (1) US4096270A (xx)
JP (1) JPS5223081A (xx)
AR (1) AR209672A1 (xx)
AT (1) AT351025B (xx)
AU (1) AU504839B2 (xx)
CA (1) CA1079284A (xx)
CH (1) CH612678A5 (xx)
CS (1) CS194774B2 (xx)
DD (1) DD126696A5 (xx)
DE (1) DE2635916A1 (xx)
DK (1) DK362676A (xx)
ES (1) ES450582A1 (xx)
FR (1) FR2320750A1 (xx)
MX (1) MX3464E (xx)
NL (1) NL7608989A (xx)
NO (1) NO144457C (xx)
PT (1) PT65456B (xx)
SE (1) SE7608959L (xx)
SU (1) SU1007556A3 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2738153A1 (de) * 1977-08-24 1979-03-08 Bayer Ag 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
US4497808A (en) * 1981-12-30 1985-02-05 Ciba-Geigy Corporation N-Oxide compounds useful in the treatment of cardiovascular ailments
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
NO144457B (no) 1981-05-25
FR2320750A1 (fr) 1977-03-11
MX3464E (es) 1980-12-09
NL7608989A (nl) 1977-02-15
SE7608959L (sv) 1977-02-13
AU504839B2 (en) 1979-11-01
US4096270A (en) 1978-06-20
DK362676A (da) 1977-02-13
JPS5223081A (en) 1977-02-21
DD126696A5 (xx) 1977-08-03
NO762790L (xx) 1977-02-15
DE2635916A1 (de) 1977-02-24
NO144457C (no) 1981-09-02
ATA568776A (de) 1978-12-15
PT65456B (fr) 1978-02-10
SU1007556A3 (ru) 1983-03-23
CA1079284A (en) 1980-06-10
ES450582A1 (es) 1977-11-16
FR2320750B1 (xx) 1979-09-28
AR209672A1 (es) 1977-05-13
CS194774B2 (en) 1979-12-31
AU1656976A (en) 1978-02-09
JPS5422986B2 (xx) 1979-08-10
PT65456A (fr) 1976-09-01
AT351025B (de) 1979-07-10

Similar Documents

Publication Publication Date Title
FR2314495B1 (xx)
FR2320750B1 (xx)
JPS5548629B2 (xx)
JPS5246148U (xx)
JPS5423736Y2 (xx)
JPS5436015B2 (xx)
JPS5431750B2 (xx)
JPS51129819U (xx)
JPS5195361A (xx)
JPS5196992A (xx)
JPS5218117U (xx)
JPS5223856U (xx)
JPS5290515U (xx)
JPS51111107U (xx)
CH597028A5 (xx)
CH592397A5 (xx)
CH596460A5 (xx)
CH597004A5 (xx)
CH602111A5 (xx)
CH596120A5 (xx)
CH597720A5 (xx)
CH598107A5 (xx)
CH595969A5 (xx)
CH595541A5 (xx)
CH595019A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased